Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.81% | 174.66 | 1.2% | $575.79m | |
| CELG | Celgene Corporation | 0.60% | 89.49 | 1.2% | $535.84m | |
| GILD | Gilead Sciences, Inc. | 0.42% | 74.01 | 0.9% | $421.63m | |
| BIIB | Biogen Inc. | -1.41% | 259.30 | 1.2% | $416.64m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.56% | 316.01 | 2.7% | $245.42m | |
| INCY | Incyte Corporation | -0.42% | 68.14 | 2.5% | $245.05m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.34% | 158.69 | 1.9% | $226.49m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.05% | 107.83 | 2.0% | $209.17m | |
| NKTR | Nektar Therapeutics | -0.88% | 85.45 | 6.0% | $201.71m | |
| ILMN | Illumina, Inc. | 0.51% | 245.85 | 3.5% | $184.02m | |
| A | Agilent Technologies, Inc. | 0.74% | 68.05 | 1.5% | $157.16m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -1.66% | 95.86 | 9.8% | $140.19m | |
| BLUE | Bluebird Bio, Inc. | -1.32% | 168.25 | 15.8% | $127.75m | |
| EXAS | Exact Sciences Corporation | 2.48% | 48.70 | 25.7% | $111.34m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.27% | 82.08 | 4.4% | $104.77m |
Company Profile
Dynavax Technologies Corp. is a clinical-stage biopharmaceutical company that uses toll-like receptor biology to discover and develop novel vaccines and therapeutics. The company's development programs are organized under its three areas of focus: vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. Its lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine. The firm's other products under pipeline are SD-101, DV1179 Autoimmune Disease and AZD1419 Asthma Therapy. Dynavax Technologies was founded by Lawrence M. Lichtenstein, Dennis A. Carson and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.